Loading people...
Irvin Akinseye is a healthcare investor who currently serves as a Technology Innovations Fellow at Brown Technology Innovations and a Third-Year MD Candidate at the Warren Alpert Medical School of Brown University. Previously, he worked as an investment Associate at Longitude Capital from 2020 to 2022 and at Vivo Capital, where he specialized in evaluating biotechnology and medical technology investments. Before entering the venture capital sector, Akinseye was an Investment Banking Analyst at Goldman Sachs, focusing primarily on financial technology financing, mergers, and acquisitions. He holds dual Bachelor of Arts degrees in Economics and Health & Human Biology from Brown University, where he also conducted early academic research building CRISPR-Cas9 genetic models. His current professional focus centers on the intersection of clinical medicine, life sciences investing, and the commercialization of early-stage academic technology transfers.
Irvin Akinseye is a key member of the investment team at Longitude Capital, where he holds the position of Associate. Longitude Capital is a leading healthcare venture capital firm dedicated to investing in biotechnology, medical technology, and health solutions companies. As an Associate, Irvin plays a crucial role in the firm's rigorous investment process, which includes conducting in-depth market research, performing financial analysis, and assisting with due diligence for potential new investments.
His primary focus areas align with Longitude Capital's broad mandate within the life sciences and healthcare sectors. This typically encompasses a wide range of therapeutic areas and technological advancements, including novel drug development, innovative medical devices, diagnostics, and digital health platforms. Irvin's analytical skills and industry insights are instrumental in evaluating the scientific merit, market potential, and financial viability of prospective portfolio companies.
Before joining Longitude Capital, Irvin Akinseye developed a strong foundation in finance and healthcare. While specific details of his prior career background are not publicly detailed, professionals in similar roles often bring experience from investment banking, consulting, or scientific research within the healthcare industry. This background equips him with the necessary expertise to assess complex scientific data and intricate business models prevalent in the life sciences sector, contributing significantly to Longitude Capital's investment decisions.
At Longitude Capital, Irvin works alongside experienced partners and principals, contributing to the firm's overall strategy of supporting companies that are developing groundbreaking solutions to address unmet medical needs. While specific notable investments attributed solely to Irvin Akinseye are not typically disclosed at the Associate level, his contributions are integral to the firm's collective investment activities and the success of its diverse portfolio. He is part of a team committed to fostering innovation and growth in companies that have the potential to transform patient care and improve health outcomes globally.
Irvin Akinseye's dedication to the healthcare investment landscape underscores Longitude Capital's commitment to identifying and nurturing the next generation of life science leaders. His work helps ensure that capital is deployed effectively to advance medical breakthroughs and bring vital therapies and technologies to market.
Irvin Akinseye is an Associate at Longitude Capital, a prominent healthcare venture capital firm. He is involved in identifying, evaluating, and executing investment opportunities within the life sciences and healthcare sectors.
As part of Longitude Capital, Irvin Akinseye focuses on investments in the life sciences and healthcare industries. This includes areas such as biotechnology, medical devices, diagnostics, and digital health solutions, aligning with the firm's broader investment mandate.
Irvin Akinseye works at Longitude Capital, a leading healthcare venture capital firm. The firm has offices in Menlo Park, California, and Greenwich, Connecticut.
